Please assess the completion status of the following clinical trial:

Trial Title: Effect of Botulinum Toxin to Hallux Valgus in Addition to Total Contact Insole

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* hallux valgus with angle of at least 20°,~* single or bilateral hallux valgus.~Exclusion Criteria:~* history of foot operations,~* rheumatoid arthritis and gouty arthritis.~* Any contraindication on BTA administration

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- botulinum toxin type A. HV angle (Type: ACTIVE_COMPARATOR): intramuscular injection of BTA into target muscle
- Normal saline, HV angle (Type: PLACEBO_COMPARATOR): intramuscular injection of normal saline into target muscle

Based on this trial design, predict the completion outcome and termination type (if applicable).